海能達(002583.SZ):預計一季度淨虧損4000萬元-7000萬元 同比減虧
格隆匯4月14日丨海能達(002583.SZ)公佈,預計一季度淨虧損4000萬元-7000萬元,同比減虧,扣非淨虧損4700萬元-7700萬元,同比減虧。
報吿期內,公司營業收入同比有所下降,主要受子公司Sepura出售影響以及國內業務下降導致,海外“一帶一路”地區及渠道業務取得良好拓展。受行業季節性因素影響,第一季度收入佔全年比重較低,導致利潤虧損。
報吿期內,公司圍繞“步步為盈”指導方針,堅持“四個高質量”發展原則,主營毛利率穩中有升,有息負債顯著降低帶來財務費用下降,使得報吿期內虧損較去年同期收窄。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.